Subscribe To
Agios pharmaceuticals to present broad set of clinical and translational data in rare blood disorders at 65th ash annual meeting and exposition
– Both Mitapivat Dose Arms Achieved Statistically Significant Hemoglobin Response in Phase 2 Portion of RISE UP Pivotal Study in Sickle Cell Disease...
November 2, 2023, 9:05 am
New apple watch to detect blood pressure, sleep apnea; health coach service planned: report
Apple reportedly plans to add a blood pressure sensor and sleep apnea detection in 2024 Apple Watch, in...
November 1, 2023, 9:57 am
Fda advisors consider crispr gene-editing treatment for sickle cell anemia
Nearly all patients treated so far have been relieved of the blood-clogging crises of the disease....
October 31, 2023, 3:43 pm
Drugmaker incyte's quarterly profit beats on lower costs
Incyte reported a third-quarter profit on Tuesday that beat analysts' estimates as lower costs helped offset weak sales of its ...
October 31, 2023, 9:48 am
Congestive heart failure: stages and types
Systolic congestive heart failure is a serious condition that occurs when the heart does not pump blood...
October 30, 2023, 3:14 pm
Understanding the symptoms of congestive heart failure
Share on Pinterest Iuliia Burmistrova/Getty Images Congestive heart failure (CHF) affects your heart’s ability to pump enough ...
October 27, 2023, 6:14 pm
Apple watch faces us import ban after feds rule it violated patent
Certain models of the Apple Watch are in violation of a patent that was issued to Masimo, a firm that created a device measuring ...
October 27, 2023, 1:50 pm
Apple watch models face us import ban in patent clash
Medical technology company Masimo Corp. on Thursday said a US trade commission has recommended banning imports of Apple Watch models that infringe its...
October 27, 2023, 4:06 am
Bristol myers squibb revenue falls on generic competition for key drug
Shares of Bristol Myers Squibb (BMY) fell Thursday after the company reported that sales of the drug maker's popular Revlimid ...
October 26, 2023, 4:55 pm
Bristol myers squibb earnings top estimates even as top-selling drug fights generic competition
Bristol Myers Squibb's revenue was in line with estimates, but fell slightly from the same period last year due to lower sales of ...
October 26, 2023, 7:05 am
Hematology analyzers market poised to reach $2.20 billion by 2033 amid rising pediatric blood disorder cases and continuous innovation: report by persistence market research
Rising blood disorder prevalence propels the U.S. to capture 90.3% market share in North America’s he...
October 25, 2023, 11:16 am
2 mega caps with comeback rallies about to start
After a stellar first half to the year, especially when compared to last year's bloodbath, the S&P 500 ...
October 23, 2023, 6:31 am
Precede biosciences unveils groundbreaking clinical data for its pioneering liquid biopsy platform at esmo 2023 and simultaneously publishes in nature medicine
Pivotal findings stem from Precede’s first-in-class platform in collaboration with Dana-Farber Cancer Institute Results underscore the immense poten...
October 21, 2023, 8:25 am
Xencor: a mid-stage clinical company with falling losses
Xencor, Inc. is a biotech company focused on the development and commercialization of anticancer medications. They have successful partnerships and li...
October 20, 2023, 11:02 pm
Us fda approves pfizer's vaccine for meningococcal disease
The U.S. Food and Drug Administration (FDA) has approved Pfizer's vaccine Penbraya, making it the first shot to protect against five groups of a deadl...
October 20, 2023, 3:41 pm
Continuous glucose monitoring systems industry projected to reach us$ 103.5 billion by 2033 | future market insights, inc.
Germany’s continuous glucose monitoring (CGM) systems industry is experiencing substantial growth, fueled by a growing patient population seeking di...
October 20, 2023, 12:30 am
3 gene editing stocks to generate super-charged gains
Gene editing is revolutionizing how the world approaches medicine. In fact, by “simply” removing cells from the body, editing them, and reintroduc...
October 18, 2023, 11:05 am
Novo nordisk buys blood pressure treatment to bolster diabtetes portfolio
Novo Nordisk (NYSE:NVO) has agreed to buy ocedurenone, a blood pressure drug for with potential applica...
October 16, 2023, 10:44 am
What defense stocks are saying about a more violent world
The bloody attack on Israel and inevitable retaliation have turned defense stocks into a gauge of the g...
October 16, 2023, 6:08 am
Down more than 50% since july, this incredible growth stock is a screaming buy on the dip
Hospitals and transplant centers increasingly rely on TransMedics Group to retrieve donated hearts, lungs, and livers, and deliver them long distances...
October 14, 2023, 5:37 am
